Core four dietary supplement system

A core four dietary supplement system comprising:

• at least one collagen system consisting of at least one peptide, and at least one enzyme inhibitor, and at least one humectant, said at least one peptide are selected from the group consisting of bovine collagen peptides type I and bovine collagen peptides type III, and combinations and mixtures thereof, said at least one enzyme inhibitor selected from the group consisting of enzyme inhibitor from Amla fruit extract, enzyme inhibitor from white tea decaffeinated extract and combinations and mixtures thereof, and said at least one humectant is selected from the group consisting of hyaluronic acid, glycerin, pyrrolidone carboxylic acid, and mixtures and combinations thereof;
• at least one microdaily EMF system consisting of Vitamin A, Vitamin C, Vitamin D3, Vitamin E, Vitamin B1, Vitamin B2, Vitamin B3, Vitamin B5, Vitamin B6, Vitamin B7, Vitamin B12, folate, calcium, magnesium, zinc, selenium, chromium, N-acetylcysteine, Coenzyme Q10, alpha-lipoic acid, natural beta carotene, curcumin, trans-resveratrol, quercetin, and green tea extract;
• a prebiotic system consisting of a prebiotic and probiotic portion, said prebiotic portion consisting of Guar Gum, Inulin, Oat Beta Glucan, Larch Arabingalactan, Rice Flour, Apple Pectin and Fiber;
• and a probiotic formulation consisting of Bifidobacterium longum, Lactobacillus rhamnosus, Lactobacillus salivarius, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus plantarum, Lactobacillus paracasei, Bifidobacterium breve, Bifidobacterium lactis, Bifidobacterium bifidum, Bifidobacterium infantis, Lactobacillus reuteri, Bacillus coagulans, and Saccharomyces Boulardii, and said probiotic portion consisting of Bifidobacterium longum, Lactobacillus rhamnosus, Lactobacillus salivarius, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus plantarum, Lactobacillus paracasei, Bifidobacterium breve, Bifidobacterium lactis, Bifidobacterium bifidum, Bifidobacterium, infantis, Lactobacillus reuteri, Bacillus coagulans, and Saccharomyces Boulardii;
• and
• an Omega-3 system comprising therapeutically active agents, said therapeutically active agents consists of:
• at least one anti-oxidation agent, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), said DHA to EPA having a ratio of at least 2:1, alpha-linolenic acid (ALA) and gamma-linolenic acid (GLA), said ALA to GLA having a ratio of at least 3:1, said at least one anti-oxidation agent is selected from a group consisting of vitamin E, vitamin C, vitamin A, glutathione, and combination and mixtures thereof, said docosahexaenoic acid and eicosapentaenoic acid are selected from the group consisting of wild caught Omega-3 fish oil, fish oil selected from the group consisting of anchovy oil, cod liver oil, pollock oil, salmon oil, tuna oil, fish roe oil, krill oil, calanus oil, squid oil, and green-shelled mussel oil, fatty fish selected from the group consisting of salmon, tuna, mackerel, and pollock, forage fish selected from the group consisting of sardines, anchovies, herring, capelin and hoki, and algae selected from the group consisting of seaweed, nori, spirulina, sea moss, and chlorella, and combinations and mixtures thereof, said alpha-linolenic acid is selected from the group consisting of organic flaxseed oil, nuts, walnuts and combinations and mixtures thereof, and said gamma-linolenic acid is selected from the group consisting of borage oil, canola oil, vegetable oil, and combinations and mixtures thereof, wherein a therapeutically effective amount of said docosahexaenoic acid to said eicosapentaenoic acid in said ratio, and a therapeutically effective amount of said alpha-linolenic acid to said gamma-linolenic acid in said ratio, function to increase beneficial effects on the brain, heart, chronic inflammation, and cognitive function.

A core four system comprising:

• at least one collagen system consisting of therapeutically active agents consisting of at least one peptide, and at least one enzyme inhibitor, and at least one humectant, said at least one peptide are selected from the group consisting of bovine collagen peptides type I and bovine collagen peptides type III, and combinations and mixtures thereof, said at least one enzyme inhibitor selected from the group consisting of enzyme inhibitor from Amla fruit extract, enzyme inhibitor from white tea decaffeinated extract and combinations and mixtures thereof, and said at least one humectant is selected from the group consisting of hyaluronic acid, glycerin, pyrrolidone carboxylic acid, and mixtures and combinations thereof;
• at least one microdaily EMF system consisting of therapeutically active agents consisting of Vitamin A, Vitamin C, Vitamin D3, Vitamin E, Vitamin B1, Vitamin B2, Vitamin B3, Vitamin B5, Vitamin B6, Vitamin B7, Vitamin B12, folate, calcium, magnesium, zinc, selenium, chromium, N-acetylcysteine, Coenzyme Q10, alpha-lipoic acid, natural beta carotene, curcumin, trans-resveratrol, quercetin, and green tea extract;
• a prebiotic system consisting of a prebiotic and probiotic therapeutically active agents, said therapeutically active agents for said prebiotic portion consisting of Guar Gum, Inulin, Oat Beta Glucan, Larch Arabingalactan, Rice Flour, Apple Pectin and Fiber;
• and a probiotic formulation consisting of Bifidobacterium longum, Lactobacillus rhamnosus, Lactobacillus salivarius, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus plantarum, Lactobacillus paracasei, Bifidobacterium breve, Bifidobacterium lactis, Bifidobacterium bifidum, Bifidobacterium infantis, Lactobacillus reuteri, Bacillus coagulans, and Saccharomyces Boulardii, and said therapeutically active agents for said probiotic portion consisting of Bifidobacterium longum, Lactobacillus rhamnosus, Lactobacillus salivarius, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus plantarum, Lactobacillus paracasei, Bifidobacterium breve, Bifidobacterium lactis, Bifidobacterium bifidum, Bifidobacterium infantis, Lactobacillus reuteri, Bacillus coagulans, and Saccharomyces Boulardii;
• and
• an Omega-3 system consisting of therapeutically active agents consisting of Vitamin E;
• docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) derived from wild caught Omega-3 fish oil and having a ratio of at least 2:1;
• and alpha-linolenic acid (ALA) derived from organic flaxseed oil and gamma-linolenic acid (GLA) derived from borage oil and having a ratio of at least 3:1, wherein a therapeutically effective amount of said docosahexaenoic acid to said eicosapentaenoic acid in said ratio, and a therapeutically effective amount of said alpha-linolenic acid to said gamma-linolenic acid in said ratio, function to increase beneficial effects on the brain, heart, chronic inflammation, and cognitive function.